Success Metrics

Clinical Success Rate
100.0%

Based on 10 completed trials

Completion Rate
100%(10/10)
Active Trials
0(0%)
Results Posted
10%(1 trials)

Phase Distribution

Ph phase_3
9
90%
Ph phase_2
1
10%

Phase Distribution

0

Early Stage

1

Mid Stage

9

Late Stage

Phase Distribution10 total trials
Phase 2Efficacy & side effects
1(10.0%)
Phase 3Large-scale testing
9(90.0%)

Highest Phase Reached

Phase 3

Trial Status & Enrollment

Completion Rate

100.0%

10 of 10 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

0

trials recruiting

Total Trials

10

all time

Status Distribution
Completed(10)

Detailed Status

Completed10

Development Timeline

Analytics

Development Status

Total Trials
10
Active
0
Success Rate
100.0%
Most Advanced
Phase 3

Trials by Phase

Phase 21 (10.0%)
Phase 39 (90.0%)

Trials by Status

completed10100%

Recent Activity

0 active trials
Showing 5 of 10
completedphase_2

Placebo-Controlled, Single-Dose Challenge Study of Gaboxadol in Adult Males With Fragile X Syndrome (FXS)

NCT06334419
completedphase_3

A Study of OV101 in Individuals With Angelman Syndrome (AS)

NCT04106557
completedphase_3

Study of MK0928 in Healthy Adult Volunteers in a Model of Insomnia (0928-006)(COMPLETED)

NCT00102167
completedphase_3

An Investigational Study of MK0928 in Adult Outpatients With Insomnia (0928-014)(COMPLETED)

NCT00103818
completedphase_3

Adult Primary Insomnia Polysomnographic Study (0928-004)(COMPLETED)

NCT00094627
View all 10 trials

Clinical Trials (10)

Showing 10 of 10 trials
NCT06334419Phase 2

Placebo-Controlled, Single-Dose Challenge Study of Gaboxadol in Adult Males With Fragile X Syndrome (FXS)

Completed
NCT04106557Phase 3

A Study of OV101 in Individuals With Angelman Syndrome (AS)

Completed
NCT00102167Phase 3

Study of MK0928 in Healthy Adult Volunteers in a Model of Insomnia (0928-006)(COMPLETED)

Completed
NCT00103818Phase 3

An Investigational Study of MK0928 in Adult Outpatients With Insomnia (0928-014)(COMPLETED)

Completed
NCT00094627Phase 3

Adult Primary Insomnia Polysomnographic Study (0928-004)(COMPLETED)

Completed
NCT00209924Phase 3

A Study of Gaboxadol in Primary Insomnia

Completed
NCT00209937Phase 3

A Prospective Active-Reference Study of Gaboxadol in Primary Insomnia

Completed
NCT00209950Phase 3

A Prospective Open-Label Extension Study of Gaboxadol in Primary Insomnia

Completed
NCT00209846Phase 3

A Study of Gaboxadol in Primary Insomnia

Completed
NCT00209963Phase 3

A Study of Gaboxadol in Primary Insomnia

Completed

All 10 trials loaded

Drug Details

Intervention Type
DRUG
Total Trials
10